Skip to main content
. 2018 Jan 1;8(1):212–222. doi: 10.7150/thno.21656

Figure 3.

Figure 3

Engineered hiPSC-MSCs delivering GPx3 significantly suppressed hepatic apoptosis and promoted liver regeneration. (A) TUNEL staining showed that more apoptotic hepatocytes were observed in the control groups. (B) Ki67 staining showed that liver regeneration was more active upon hiPSC-MSC-GPx3 treatment, 400×. Arrows indicated the positive signals of liver regeneration.